Vervaardiging van farmaceutische grondstoffen
NACE 21100Active companies671
Bankruptcies (5y)3
Failure rate0.45%
Regions covered4
Provinces covered11
Bankruptcies and the failure rate are attributed by each company's current primary NACE, not the NACE at the time of bankruptcy (which the gazette does not record).
Sector key figures
fiscal year 2024 · median over 46 filed annual accounts (NACE division 21)Median solvency
46.9%
Median equity
€108k
Median net result
€-1k
Annual accounts in sample
46
Source: NBB annual accounts, all schema types combined. Medians computed internally.
Regional split
by regionVlaanderen
72 · 50.7%
Wallonië
53 · 37.3%
Brussel
14 · 9.9%
Unknown
3 · 2.1%
Recent bankruptcies in this sector
3| Date | Company |
|---|---|
| 10-03-2026 | Amalus Therapeutics
BE 0803.929.268 |
| 27-10-2025 | UNIZIMA
BE 0744.643.759 |
| 06-12-2023 | NEWCOM SERVICES
BE 0537.404.744 |
Geographic distribution
by province · based on the establishment addressWest Flanders
WVL
6
East Flanders
OVL
21
Antwerp
ANT
21
Flemish Brabant
VLB
17
Limburg
LIM
7
Brussels
BRU
14
Hainaut
HAI
16
Walloon Brabant
WBR
17
Namur
NAM
3
Liège
LIE
12
Luxembourg
LUX
5
fewer
moremax 21